Drug Utilization Evaluation among the Patients with Renal Disease In a Tertiary Care Hospital

Authors

  • Amit Kumar Department of Pharmacy Practice, Aditya College of Pharmacy, Surampalem, Andhra Pradesh, India
  • V Asha Rani Department of Pharmacy Practice, Aditya College of Pharmacy, Surampalem, Andhra Pradesh, India
  • K Prince Department of Pharmacy Practice, Aditya College of Pharmacy, Surampalem, Andhra Pradesh, India
  • P Srilakshmi Department of Pharmacy Practice, Aditya College of Pharmacy, Surampalem, Andhra Pradesh, India
  • S Prathana Department of Pharmacy Practice, Aditya College of Pharmacy, Surampalem, Andhra Pradesh, India
  • G Manita Department of Pharmacy Practice, Aditya College of Pharmacy, Surampalem, Andhra Pradesh, India

DOI:

https://doi.org/10.61427/jcpr.v2.i3.2022.66

Keywords:

Chronic Kidney Disease, Drug Utilization Evaluation, Renal disease

Abstract

Aim: The main aim of this study was to conduct drug utilization evaluation among the patients with renal disease in a tertiary care hospital.
Materials and Methods: An observational study was conducted among 102 patients for a period of six months in a tertiary care teaching hospital. Both male and female genders with renal diseases undergoing pharmacological therapy who were aged between 20-70 years were included in this study. Pregnant and lactating women and patients with incomplete laboratory data were excluded from this study. Results: Out of 102 patients included in this study, 54.9% (n=56) were male and 45.1% (n=46) were female. In this study, antibiotics (17.3%) were prescribed mostly and anti-fungals (1.9%) were found to be less prescribed. Among the antibiotics used, combination of Piperacillin + ?-lactamase inhibitors were prescribed mostly followed by combination of Cephalosporins + ?-lactamase inhibitors and Aminoglycosides were prescribed leastly. Conclusion: Drug utilization evaluation plays a major role to evaluate and improve drug use especially in a country like India, where illiteracy, poverty, different medicine system practices, dispensing without prescription, predominance in medical and marketing field and lack of drug information is evident. It is critical that standard guidelines in the therapeutic management to be developed and adopted that will help to prescribe the medication based on the evidence, hence improves the overall quality of drug use and ensures betterment of patients.

Downloads

Download data is not yet available.

References

Noel D, Landais P. Epidemiology of chronic kidney disease. Rev Prat, 2012; 62(2):197.

Haileamlak A. Chronic Kidney Disease is on the Rise. Ethiop J Health Sci, 2018; 28(6): 681-2.

Management Sciences for Health and World Health Organization. 2007. Drug and Therapeutics Committee Training Course. Submitted to the U.S. Agency for International Development by the Rational Pharmaceutical Management Plus Program. Arlington, VA: Management Sciences for Health.

Wertheimer AI. The defined daily dose system (DDD) for drug utilization review. Hosp Pharm, 1986; 21(3): 233-4, 239-41, 258.

Mallappallil Mary, Friedman EA et al. Chronic kidney disease in the elderly: Evaluation and management. Clin Pract (Lond), 2014; 11(5): 525-35.

Juan JC, Hecking M, Chesnaye N et al. Sex and gender disparities in the epidemiology and outcomes of chronic kidney disease. Nat Rev Nephrol, 2018; 14: 151-64.

Carter BL. Dosing of antihypertensive medications in patients with renal insufficiency. J Clin Pharmacol, 1995; 35(1):81-6.

Sica DA. Diuretic use in renal disease. Nat Rev Nephrol, 2011; 8(2):100-9.

Published

2022-07-28
Statistics
462 Views | 271 Downloads
Citatons

How to Cite

Kumar, A. ., V. Asha Rani, K. Prince, P. Srilakshmi, S. Prathana, and G. Manita. “Drug Utilization Evaluation Among the Patients With Renal Disease In a Tertiary Care Hospital”. Journal of Clinical and Pharmaceutical Research, vol. 2, no. 3, July 2022, pp. 52-54, doi:10.61427/jcpr.v2.i3.2022.66.

Issue

Section

Research Articles

Most read articles by the same author(s)

1 2 > >>